Bausch Health reports Court of Appeals heard oral arguments on patent dispute

Bausch Health and its gastroenterology business Salix Pharmaceuticals announced that, as scheduled, oral arguments were heard today at the U.S. Court of Appeals for the Federal Circuit in the matter of “Salix Pharmaceuticals, LTD et al v. Norwich Pharmaceuticals, Inc.” As expected, no ruling was issued by the Court following these oral arguments, the company stated. “We were pleased to have had the opportunity to present our oral arguments to the Court of Appeals today,” Thomas Appio, Chief Executive Officer said. “We look forward to the Court’s decision in due course. We will continue to advocate for the safety of patients who have benefited from continued access to XIFAXAN, and look forward to continuing to serve those patients.”